BioTech

AveXis, a Novartis company, announced interim data from ongoing trials of the investigational product Zolgensma or onasemnogene abeparvovec-xioi; AVXS-101 that showed positive results across a broad spectrum of patients with spinal muscular atrophy or SMA.

Sobi™ to Acquire Synagis® US Rights From AstraZeneca - Creates a Platform for Global Growth - read this article along with other careers information, tips and advice on BioSpace

TITUSVILLE, N.J., March 5, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administratio

My WordPress Blog

Vertex today announced the appointment of Charles Wagner as Executive Vice President and Chief Financial Officer, effective April 10, 2019.

Charles River and Toxys have entered into an agreement to offer access to ToxTracker® in North America.

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved both VYNDAQEL® (tafamidis meglumine) and VYNDAMAX

PharmaCyte Biotech announces publication of U.S. patent application for cancer therapies.

DowDuPont (DWDP) said that its board has approved the separation of DowDuPont's Materials Science Division, which will become the new Dow on April 1. In connection with the separation, the DowDuPont board of directors declared a pro rata dividend of all of the outstanding shares of common stock of Dow Inc.

MARLBOROUGH, Mass., Dec. 27, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire th